2015
$40M
from 6 investors over 6 rounds
APRINOIA Therapeutics raised $40M on December 28, 2021
Investors: Yantai Dongcheng Pharmaceutical Group Co., Ltd and IMM Private Equity
APRINOIA Therapeutics raised $11M on January 16, 2018
Investors: TaiAn Technologies Corporation and shangpharm
APRINOIA Therapeutics raised $6M on May 20, 2016
Investors: Company K Partners and IMM Investment Corp.